H.C. Wainwright Maintains Oramed Pharmaceuticals(ORMP.US) With Hold Rating
H.C. Wainwright analyst Ram Selvaraju maintains $Oramed Pharmaceuticals(ORMP.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 40.8% and a total average return of 0
Oramed Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Oramed Pharmaceuticals (ORMP): Shareholder Letter Spurs Bullish Trend
Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech.
Express News | Oramed Pharmaceuticals: Htit Committing $70 Mln in Cash, Co Investing $25 Mln in Cash & Stock in Jv
Express News | Oramed Pharmaceuticals Inc: Jv With Chinese Partner, Htit
Express News | Oramed Pharmaceuticals - Authorized Common Stock Repurchase Plan Allowing for Buy-Back of up to $20 Mln in Maximum Value of Its Common Stock
Express News | Oramed Pharmaceuticals Inc. Announces the Buy-Back of Its Common Stock
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Scilex Holding Signs Commitment Letter for $100 Million Financing
Oramed Pharmaceuticals Former CFO Avraham Gabay to Rejoin Company as CFO June 18
Express News | Oramed Pharmaceuticals Inc - on June 6, Appointed Avraham Gabay to Serve as CFO, Treasurer and Secretary
HC Wainwright & Co. Reiterates Neutral on Oramed Pharmaceuticals
Oramed Pharmaceuticals Analyst Ratings
Compugen Appoints David Silberman As Its New CFO Effective August 15, 2024, Taking Over From Alberto Sessa Who Will Depart On The Same Day
Oramed Pharmaceuticals Seeks New CFO After Resignation
Oramed Pharmaceuticals (ORMP.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $666,000; earnings per share of $0.04, previous value of -$0.08, and expected value of $0.02.
Oramed Pharmaceuticals (ORMP.US): The 2024 Q1 financial report achieved revenue of $0, with a previous value of $666,000; earnings per share of $0.04, previous value of -$0.08, and expected value of $0.02.
Oramed Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Earnings Week Ahead: Disney, Palantir, Shopify, Uber, Plug Power and More
Oramed Pharmaceuticals Welcomes New Audit Committee Chair